
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
Luther A. Bartelt, Alena J. Markmann, Bridget Nelson, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 12
Luther A. Bartelt, Alena J. Markmann, Bridget Nelson, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 12
Showing 12 citing articles:
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2023, Iss. 2
Open Access | Times Cited: 31
Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 29
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 29
Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
Mayo Clinic Proceedings Innovations Quality & Outcomes (2023) Vol. 7, Iss. 5, pp. 499-513
Open Access | Times Cited: 28
Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients’ variants
Tuba Khawaja, Mikael Kajova, Iris Levonen, et al.
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 423-433
Open Access | Times Cited: 3
Tuba Khawaja, Mikael Kajova, Iris Levonen, et al.
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 423-433
Open Access | Times Cited: 3
Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort
Michael L. Mallory, Jennifer E. Munt, Tara M. Narowski, et al.
Science Advances (2024) Vol. 10, Iss. 24
Open Access | Times Cited: 1
Michael L. Mallory, Jennifer E. Munt, Tara M. Narowski, et al.
Science Advances (2024) Vol. 10, Iss. 24
Open Access | Times Cited: 1
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, et al.
Life (2024) Vol. 14, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, et al.
Life (2024) Vol. 14, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Passive antibody therapy in emerging infectious diseases
Xiaoming Yang
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1117-1134
Closed Access | Times Cited: 3
Xiaoming Yang
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1117-1134
Closed Access | Times Cited: 3
Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake
Michael L. Mallory, Jennifer E. Munt, Tara M. Narowski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Michael L. Mallory, Jennifer E. Munt, Tara M. Narowski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma
Caro Verbrugghe, Elise Wouters, Rosalie Devloo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Caro Verbrugghe, Elise Wouters, Rosalie Devloo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center
Heather Root, Matt Gilleskie, Chih-Huan Lu, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0277707-e0277707
Open Access | Times Cited: 2
Heather Root, Matt Gilleskie, Chih-Huan Lu, et al.
PLoS ONE (2022) Vol. 17, Iss. 12, pp. e0277707-e0277707
Open Access | Times Cited: 2
Commentary on “Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study”
Michael J. Joyner, Nigel Paneth
mBio (2022) Vol. 13, Iss. 6
Open Access
Michael J. Joyner, Nigel Paneth
mBio (2022) Vol. 13, Iss. 6
Open Access